06U337ZSupplement Esophageal Vein with Autologous Tissue Substitute, Percutaneous Approach
- Billable / Specific Code
06U337Z is a billable ICD-10-PCS procedure code for Supplement Esophageal Vein with Autologous Tissue Substitute, Percutaneous Approach. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to 9 MS-DRGs. The root operation Supplement involves putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | 0 | Medical and Surgical |
| 2 | Body System | 6 | Lower Veins |
| 3 | Operation | U | Supplement |
| 4 | BodyPart | 3 | Esophageal Vein |
| 5 | Approach | 3 | Percutaneous |
| 6 | Device | 7 | Autologous Tissue Substitute |
| 7 | Qualifier | Z | No Qualifier |
Convert to ICD-9-PCS
Closest ICD-9-PCS equivalents for 06U337Z under the General Equivalence Mappings.
Similar Procedure Codes
Questions About 06U337Z
Is 06U337Z a billable code?
Yes. 06U337Z is a complete seven-character ICD-10-PCS code, specific enough to report Supplement Esophageal Vein with Autologous Tissue Substitute, Percutaneous Approach on inpatient claims from October 1, 2025 through September 30, 2026.
What do the characters in 06U337Z mean?
06U337Z breaks down character by character: the 1st character 0 is the Section (Medical and Surgical); the 2nd character 6 is the Body System (Lower Veins); the 3rd character U is the Operation (Supplement); the 4th character 3 is the BodyPart (Esophageal Vein); the 5th character 3 is the Approach (Percutaneous); the 6th character 7 is the Device (Autologous Tissue Substitute); the 7th character Z is the Qualifier (No Qualifier).
What MS-DRG does 06U337Z group to?
On an inpatient stay, Supplement Esophageal Vein with Autologous Tissue Substitute, Percutaneous Approach maps to MS-DRGs 252, 253, 254, 907, 908, 909, 957, 958, 959, with relative weights from 1.3127 to 7.6199. The MS-DRG sets the fixed Medicare payment for the stay.
What is the ICD-9-PCS equivalent of 06U337Z?
Under the General Equivalence Mappings, Supplement Esophageal Vein with Autologous Tissue Substitute, Percutaneous Approach crosswalks to ICD-9-PCS 39.56. The mapping is approximate, so confirm it fits the documentation.
